MUSTANG BIO, INC. — Director's Dealing 2018

Nov 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2018-06-14

Reporting Person: Chill Adam J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-14	COMMON STOCK	A	10000	$0.00	Acquired	60000	Direct
2018-11-08	COMMON STOCK	A	2000	$5.34	Acquired	62000	Direct
2018-11-12	COMMON STOCK	A	1000	$4.85	Acquired	63000	Direct

Footnotes

F1: 60,000 shares are restricted Common Stock which vest over various time periods.

F2: Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 8, 2018, was $4.90 to $6.06. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.